Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_assertion type Assertion NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_head.
- NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_assertion description "[Therapeutically, KRAS mutation testing has maximum utility in stratifying metastatic colorectal carcinoma and lung cancer patients for treatment with targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_provenance.
- NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_assertion evidence source_evidence_literature NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_provenance.
- NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_assertion SIO_000772 25487540 NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_provenance.
- NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_assertion wasDerivedFrom befree-2016 NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_provenance.
- NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_assertion wasGeneratedBy ECO_0000203 NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_provenance.